ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
7.68
+0.21 (2.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Employees
ORIC Pharmaceuticals had 100 employees as of December 31, 2023. The number of employees increased by 14 or 16.28% compared to the previous year.
Employees
100
Change (1Y)
14
Growth (1Y)
16.28%
Revenue / Employee
n/a
Profits / Employee
-$1,278,470
Market Cap
545.49M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100 | 14 | 16.28% |
Dec 31, 2022 | 86 | 8 | 10.26% |
Dec 31, 2021 | 78 | 17 | 27.87% |
Dec 31, 2020 | 61 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ORIC News
- 4 days ago - ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates - GlobeNewsWire
- 15 days ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones - GlobeNewsWire
- 6 weeks ago - ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire